Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).
Llamas-Velasco M, Hospital M, López-Ferrer A, Herranz P, Ruíz-Villaverde R, Mateu A, García-Latasa FJ, Rivera R, Fernández-Freire LR, Alcazar ED, Santos S, Arias S, Gónzalez-Cantero A, Belinchon I, Carretero G, Ferran M, Ruiz-Genao D, Eiris N, Sahuquillo A, Mataix J, Carrascosa JM, Cueva P, Salgado-Boquete L.
Llamas-Velasco M, et al. Among authors: arias s.
Pharmacy (Basel). 2026 Apr 24;14(3):63. doi: 10.3390/pharmacy14030063.
Pharmacy (Basel). 2026.
PMID: 42200950
Free PMC article.